- Home
- ADUR vs ZOM Comparison
ADUR vs ZOM Comparison
Compare ADUR & ZOM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADUR
- ZOM
- Stock Information
- Founded
- ADUR 2011
- ZOM 2015
- Country
- ADUR Canada
- ZOM United States
- Employees
- ADUR N/A
- ZOM N/A
- Industry
- ADUR
- ZOM Biotechnology: Pharmaceutical Preparations
- Sector
- ADUR
- ZOM Health Care
- Exchange
- ADUR NYSE
- ZOM Nasdaq
- Market Cap
- ADUR 154.9M
- ZOM 117.6M
- IPO Year
- ADUR N/A
- ZOM N/A
- Fundamental
- Price
- ADUR $6.13
- ZOM $0.12
- Analyst Decision
- ADUR
- ZOM
- Analyst Count
- ADUR 0
- ZOM 0
- Target Price
- ADUR N/A
- ZOM N/A
- AVG Volume (30 Days)
- ADUR 66.1K
- ZOM 5.1M
- Earning Date
- ADUR 01-01-0001
- ZOM 11-07-2024
- Dividend Yield
- ADUR N/A
- ZOM N/A
- EPS Growth
- ADUR N/A
- ZOM N/A
- EPS
- ADUR N/A
- ZOM N/A
- Revenue
- ADUR $247,485.00
- ZOM $26,727,000.00
- Revenue This Year
- ADUR N/A
- ZOM $36.75
- Revenue Next Year
- ADUR N/A
- ZOM $14.92
- P/E Ratio
- ADUR N/A
- ZOM N/A
- Revenue Growth
- ADUR 98.59
- ZOM 11.33
- 52 Week Low
- ADUR $1.34
- ZOM $0.12
- 52 Week High
- ADUR $7.00
- ZOM $0.22
- Technical
- Relative Strength Index (RSI)
- ADUR N/A
- ZOM 44.48
- Support Level
- ADUR N/A
- ZOM $0.12
- Resistance Level
- ADUR N/A
- ZOM $0.12
- Average True Range (ATR)
- ADUR 0.00
- ZOM 0.00
- MACD
- ADUR 0.00
- ZOM -0.00
- Stochastic Oscillator
- ADUR 0.00
- ZOM 28.18
About ADUR ADURO CLEAN TECHNOLOGIES INC
Aduro Clean Technologies Inc is a developer of patented water-based technologies to chemically recycle plastics and transform heavy crude and renewable oils into feedstocks and higher-value fuels. The company's technology activates unique properties of water in a chemistry platform that operates at relatively low temperatures and costs.
About ZOM Zomedica Corp.
Zomedica Corp is a veterinary health company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians. The company's product portfolio includes diagnostics and therapeutics that emphasize patient health and practice health. The company is focused on the final development and commercialization of its TRUFORMA platform, which detects thyroid disorders in dogs & cats and adrenal disorders in dogs. Its operations are comprised of two reportable segments namely Diagnostic and Therapeutic Devices. It earns the majority of revenue from the therapeutics segment.